Automated Sample Preparation Technology Market (2025 - 2033) Size, Share & Trends Analysis Report By Product & Service, By Application (Clinical Diagnostics, Drug Discovery & Development), By End Use, By Region, And Segment Forecasts

Automated Sample Preparation Technology Market Summary

The global automated sample preparation technology market size was estimated at USD 1.17 billion in 2024 and is projected to reach USD 2.58 billion by 2033, expanding at a CAGR of 9.62% from 2025 to 2033. The market growth is driven by the increasing demand for high-throughput, accurate, and reproducible workflows in research, clinical diagnostics, and drug discovery.

Rising adoption of automation in genomics, proteomics, and molecular diagnostics, coupled with technological advancements in robotics and AI-integrated platforms, is further accelerating growth. Additionally, growing investments in life sciences R&D by pharmaceutical, biotechnology, and academic institutions are supporting the deployment of advanced automated systems.

Adoption in Omics and Drug Discovery

The global shift toward precision medicine and advanced molecular research has significantly accelerated the adoption of automated sample preparation technologies across genomics, proteomics, metabolomics, and drug discovery. Laboratories and research institutes are increasingly leveraging automation to handle large volumes of complex samples with high precision, reducing variability and improving reproducibility. In genomics, automated systems are essential for preparing DNA and RNA samples for next-generation sequencing (NGS), enabling faster data generation and more reliable results. Similarly, proteomics and metabolomics workflows benefit from automated sample handling, as these applications require meticulous processing to ensure accurate profiling of proteins, metabolites, and biomolecules.

In drug discovery, automation is becoming indispensable for high-throughput screening, compound testing, and biomarker analysis. Pharmaceutical and biotechnology companies are deploying automated sample preparation platforms to accelerate pre-clinical and clinical studies, minimize human error, and ensure consistent sample quality. These technologies facilitate rapid processing of thousands of samples, allowing researchers to identify potential drug candidates efficiently. Furthermore, the integration of robotics and AI-driven systems in automated workflows enhances precision, reduces hands-on time, and enables real-time data analysis, optimizing both speed and reliability.

Academic and research institutions are also contributing to market growth by adopting automated platforms for complex multi-omics studies. These institutions increasingly rely on automation to scale experiments, improve reproducibility, and reduce labor-intensive tasks, particularly in large-scale studies involving genomics, transcriptomics, and proteomics. By enabling seamless handling of diverse sample types and volumes, automated systems help researchers focus on data interpretation and discovery rather than manual sample preparation, ultimately advancing scientific research outcomes.

Overall, the increasing adoption of automated sample preparation technologies across genomics, proteomics, metabolomics, and drug discovery is driven by the need for high-throughput, accurate, and reproducible workflows. Technological advancements, combined with growing investments in life sciences research, are accelerating deployment across pharmaceutical, biotechnology, and academic sectors. As the demand for precision, efficiency, and scalability continues to rise, the market for automated sample preparation technologies is poised for sustained growth in the coming years.

Efficiency and Turnaround Time

The growing emphasis on reducing turnaround time and enhancing operational efficiency is driving the adoption of automated sample preparation technologies across research and clinical laboratories. Manual sample processing is often time-consuming, labor-intensive, and prone to variability, which can delay results and affect data reliability. Automated systems streamline workflows, enabling rapid, high-throughput sample processing with minimal human intervention. This efficiency is particularly critical in clinical diagnostics, where faster result delivery directly impacts patient care and decision-making.

Pharmaceutical and biotechnology companies are also leveraging automation to accelerate drug discovery and development timelines. By integrating automated platforms into laboratory operations, organizations can standardize procedures, minimize errors, and optimize resource utilization. The reduction in hands-on time allows researchers to focus on analysis and interpretation rather than repetitive tasks, ultimately improving productivity and throughput. As the demand for faster, more reliable results continues to rise, automated sample preparation technologies are becoming essential tools for laboratories seeking to enhance operational performance and maintain a competitive edge.

Market Concentration & Characteristics

The automated sample preparation technology industry exhibits a high level of innovation, driven by advancements in robotics, AI integration, and workflow automation. Continuous product development enhances accuracy, scalability, and throughput, positioning automation as a critical enabler of efficiency and competitiveness in research, diagnostics, and pharmaceutical applications.

The market for automated sample preparation technology reflects moderate M&A activities, with companies pursuing strategic acquisitions and partnerships to expand product portfolios, strengthen technological capabilities, and enhance market presence. These activities are primarily focused on integrating automation with advanced analytical platforms and catering to the growing demand for high-throughput solutions.

Regulations play a crucial role in the automated sample preparation technology industry by ensuring product safety, reliability, and compliance with international quality standards. Stringent guidelines in clinical diagnostics, pharmaceuticals, and biotechnology drive manufacturers to maintain validated processes, promote standardization, and foster trust among end users, ultimately influencing market adoption and competitiveness.

Product expansion in the automated sample preparation technology industry is driven by growing demand for advanced automation, integration with next-generation sequencing and mass spectrometry platforms, and the need for high-throughput, precise, and reproducible workflows. Companies are innovating to deliver scalable, cost-efficient solutions that cater to diverse research and clinical applications.

Regional expansion in the automated sample preparation technology market is driven by growing investments in life sciences research, rising adoption of molecular diagnostics, and the increasing demand for high-throughput laboratory automation. Emerging markets are witnessing accelerated adoption as governments and private players strengthen healthcare infrastructure and research capabilities.

Product & Service Insights

The instruments segment dominated the market in 2024 and is expected to grow the fastest throughout the forecast period. This growth can be attributed to the increasing demand for advanced automated platforms that enhance accuracy, efficiency, and throughput in sample preparation workflows. Continuous technological innovations, including the integration of robotics, AI, and high-throughput systems, are further driving adoption across research laboratories, clinical diagnostics, and pharmaceutical companies. Growing investments in life sciences R&D and the rising need for reliable, reproducible results are strengthening segment growth. Additionally, the expansion of next-generation sequencing, proteomics, and drug discovery applications is fueling greater reliance on instruments, positioning this segment as the key revenue contributor.

The software & services segment is expected to grow significantly during the forecast period, driven by increasing demand for workflow integration, data management, and advanced analytics in automated sample preparation. Cloud-based platforms, AI-enabled solutions, and technical support services are enhancing efficiency, scalability, and reproducibility. Additionally, the growing need for customized software solutions and maintenance services to optimize instrument performance is further fueling segment growth, making it a vital contributor to market expansion.

Application Insights

The clinical diagnostics segment dominated the automated sample preparation technology market with a share of 33.79% in 2024, driven by the rising burden of chronic and infectious diseases and the growing need for accurate, rapid, and reliable testing. Increasing adoption of molecular diagnostics, next-generation sequencing, and automation technologies in diagnostic laboratories has further accelerated demand. Automated sample preparation enhances workflow efficiency, reduces turnaround times, and minimizes human error, making it a critical component in clinical settings and reinforcing the segment’s strong market position during the forecast period.

The genomics and next-generation sequencing (NGS) segment is witnessing significant growth over the forecast period, driven by the increasing demand for high-throughput genetic analysis, personalized medicine, and advanced research applications. Automated sample preparation technologies are critical in this segment, ensuring accuracy, reproducibility, and efficiency in processing DNA and RNA samples. Rising investments in genomics research, expanding adoption of NGS in clinical diagnostics, and the need for faster, scalable workflows are further propelling market expansion, positioning this segment as a key market growth driver.

End Use Insights

The pharmaceutical & biotechnology companies segment led the automated sample preparation technology industry, capturing the largest share of 40.64% in 2024. This can be attributed to the rising investments in drug discovery, development, and high-throughput research. Increasing adoption of automated sample preparation technologies enables these companies to enhance workflow efficiency, ensure reproducibility, and reduce manual errors. The need for faster and more accurate sample processing in preclinical and clinical studies, coupled with growing R&D expenditure, continues to reinforce the segment’s market dominance and positions it as a key driver of growth within the automated sample preparation technology industry.

The academic & research institutes segment is projected to grow at the fastest CAGR during the forecast period, driven by increasing investments in life sciences research and the rising need for high-throughput, accurate, and reproducible workflows. Adoption of automated sample preparation technologies enables efficient handling of complex experiments in genomics, proteomics, and metabolomics. Additionally, the emphasis on accelerating scientific discoveries, reducing manual intervention, and improving laboratory productivity is fueling rapid growth in this segment globally.

Regional Insights

The North America automated sample preparation technology market held the largest global revenue share in 2024, supported by strong investments in life sciences research, advanced healthcare infrastructure, and widespread adoption of laboratory automation. The presence of leading pharmaceutical, biotechnology, and clinical research organizations, coupled with increasing demand for high-throughput and accurate sample processing, has further strengthened the region’s market position. Additionally, continuous technological advancements, integration of robotics and AI in automated workflows, and supportive regulatory frameworks have driven adoption across genomics, proteomics, molecular diagnostics, and drug discovery applications in North America.

U.S Automated Sample Preparation Technology Market Trends

The U.S. automated sample preparation technology industry is highly competitive, driven by the presence of leading pharmaceutical, biotechnology, and diagnostics companies, continuous technological innovations, and rising demand for high-throughput, accurate, and reproducible workflows. Increasing investments in life sciences R&D, integration of AI and robotics in laboratory automation, and strategic collaborations among key players further intensify competition and drive market growth across the country.

Europe Automated Sample Preparation Technology Market Trends

The Europe automated sample preparation technology industry is witnessing steady growth, owing to increasing investments in life sciences research, expanding pharmaceutical and biotechnology activities, and rising adoption of advanced laboratory automation. The demand for high-throughput, accurate, and reproducible sample processing in genomics, proteomics, clinical diagnostics, and drug discovery is further driving market expansion. Additionally, supportive government initiatives, stringent regulatory standards, and continuous technological advancements in robotics and AI-integrated platforms are enhancing workflow efficiency and reliability. The presence of leading market players and growing collaborations between academic institutions and industry stakeholders are also contributing to the steady regional market growth. 

The UK automated sample preparation technology market is expanding, driven by growing investments in life sciences and healthcare research, increasing adoption of laboratory automation, and rising demand for high-throughput, accurate, and reproducible sample processing. The expansion of clinical diagnostics, genomics, and pharmaceutical R&D, along with supportive government initiatives and technological advancements, is further fueling market growth across the country.

The automated sample preparation technology market in Germany is growing, owing to increasing investments in life sciences research, expanding pharmaceutical and biotechnology activities, and rising adoption of advanced laboratory automation. The demand for high-throughput, accurate, and reproducible workflows in clinical diagnostics, genomics, and drug discovery, along with supportive government initiatives and technological advancements, is further driving market growth in the country.

Asia Pacific Automated Sample Preparation Technology Market Trends

The Asia Pacific automated sample preparation technology industry is expected to witness the fastest growth, registering a CAGR of 10.11% during the forecast period. This growth is driven by increasing investments in healthcare and life sciences research, rising adoption of advanced laboratory automation, and expanding clinical diagnostics and pharmaceutical activities. Government initiatives to modernize laboratories, coupled with growing demand for high-throughput, accurate, and reproducible sample processing in genomics, proteomics, and drug discovery, are further fueling market expansion across the region.

The China automated sample preparation technology market is growing rapidly, driven by increasing investments in biotechnology and pharmaceutical R&D, rising adoption of advanced laboratory automation, and the expanding clinical diagnostics sector. Government initiatives to enhance healthcare infrastructure, coupled with the growing demand for high-throughput and accurate sample processing in genomics, proteomics, and drug discovery, are further fueling market growth. Technological advancements and partnerships with global players are also supporting the rapid expansion of the industry in China.

The automated sample preparation technology market in Japan is growing, driven by rising investments in life sciences research, increasing adoption of advanced laboratory automation, and the demand for high-throughput, precise, and reproducible workflows. Expansion of clinical diagnostics, genomics, and pharmaceutical R&D, along with supportive government initiatives, is further accelerating market growth in the country.

MEA Automated Sample Preparation Technology Market Trends

The Middle East and Africa (MEA) automated sample preparation technology industry is emerging, driven by increasing investments in healthcare and research infrastructure, rising adoption of laboratory automation, and growing demand for accurate, high-throughput diagnostics. Government initiatives, expanding pharmaceutical and biotechnology activities, and the focus on modernizing clinical laboratories are further fueling market growth across the region.

The Kuwait automated sample preparation technology market is emerging, driven by increasing investments in healthcare infrastructure, growing adoption of advanced laboratory automation, and rising demand for accurate and high-throughput diagnostics. Expansion of research initiatives and government support for life sciences development further contribute to market growth in the region.

Key Automated Sample Preparation Technology Company Insights

The global automated sample preparation technology market is characterized by the presence of several leading players, including Thermo Fisher Scientific, Inc.; Agilent Technologies, Inc.; PerkinElmer, Inc.; QIAGEN N.V.; Beckman Coulter (Danaher Corporation); Tecan Group Ltd.; Eppendorf AG; Hamilton Company; Bio-Rad Laboratories, Inc.; and Merck KGaA. These companies dominate the market through extensive product portfolios, technological innovations, and strong global distribution networks. Thermo Fisher Scientific holds a prominent position, leveraging its comprehensive range of automated instruments, consumables, and software solutions to cater to genomics, proteomics, clinical diagnostics, and drug discovery applications.

Agilent Technologies and PerkinElmer maintain significant market shares by focusing on high-precision, scalability, and integrated automation solutions. Agilent’s offerings empha size high-throughput sample processing and compatibility with next-generation sequencing and mass spectrometry workflows. PerkinElmer has strengthened its market presence through acquisitions and product diversification, providing laboratories with tailored automated solutions that enhance efficiency and reproducibility. Similarly, QIAGEN N.V. is recognized for its expertise in molecular diagnostics and sample preparation kits, driving adoption across genomics and clinical research.

Mid-sized players such as Beckman Coulter (Danaher Corporation), Tecan Group Ltd., and Eppendorf AG have secured competitive positions by offering specialized, flexible, and user-friendly automated systems. Beckman Coulter focuses on workflow optimization and high-throughput sample handling, while Tecan and Eppendorf empha size modular, scalable platforms suitable for diverse laboratory environments. Hamilton Company differentiates itself through precision liquid handling systems, supporting both research and clinical applications. These companies leverage innovation, technical support, and customization to maintain strong client relationships and expand their regional presence.

Bio-Rad Laboratories, Inc. and Merck KGaA also contribute to market growth with robust automation solutions and integrated software platforms. Bio-Rad emphasizes quality control, reproducibility, and laboratory efficiency, whereas Merck focuses on expanding product offerings for genomics, proteomics, and drug discovery. Collectively, these companies compete on the basis of technology innovation, strategic collaborations, and mergers & acquisitions, which not only enhance market share but also accelerate the development of next-generation automated sample preparation technologies. The competitive landscape is therefore marked by continuous investment in R&D, regional expansion, and product diversification to address the growing global demand for accurate, high-throughput laboratory automation.

Recent Developments

• In April 2025, QIAGEN announced its strategic plan to launch three new sample preparation instruments, QIAsymphony Connect, QIAsprint Connect, and QIAmini, by 2026, aimed at enhancing laboratory automation, increasing operational efficiency, and addressing both high- and low-throughput market segments.

• In May 2025, MGI Tech launched its next-generation automation portfolio, comprising the PrepALL flexible liquid handling system and the enhanced Smart8 platform, aimed at optimizing laboratory workflows in genomics, drug discovery, and molecular diagnostics, while enabling scalable, AI-driven automation solutions for research and clinical laboratories.

Automated Sample Preparation Technology Market Report Scope

Global Automated Sample Preparation Technology Market Report Segmentation

This report forecasts revenue growth and provides an analysis on the latest trends in each of the sub-segments from 2021 to 2033. For this report, Grand View Research has segmented the global automated sample preparation technology market report based on product & service, application, end use, and region:

• Product & Service Outlook (Revenue, USD Million, 2021 - 2033)

  • Instruments

  • Consumables

  • Software & Services

• Application Outlook (Revenue, USD Million, 2021 - 2033)

  • Clinical Diagnostics

  • Genomics & Next-Generation Sequencing (NGS)

  • Proteomics & Metabolomics

  • Drug Discovery & Development

  • Others

• End Use Outlook (Revenue, USD Million, 2021 - 2033)

  • Pharmaceutical & Biotechnology Companies

  • Academic & Research Institutes

  • Hospitals & Diagnostic Laboratories

  • Others

• Regional Outlook (Revenue, USD Million, 2021 - 2033)

  • North America

    • U.S.

    • Canada

    • Mexico

  • Europe

    • Germany

    • UK

    • France

    • Italy

    • Spain

    • Denmark

    • Sweden

    • Norway

  • Asia Pacific

    • China

    • India

    • Japan

    • South Korea

    • Australia

    • Thailand

  • Latin America

    • Brazil

    • Argentina

  • Middle East and Africa (MEA)

    • South Africa

    • Saudi Arabia

    • UAE

    • Kuwait